REGULUS THERAP (RGLS)
$1.74
0.01 (0.57%)
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Previous Close
$1.75
Market Cap
115.93M
PE Ratio
-2.11
EPS
-0.8246
Volume (Avg. Vol.)
2.58M
Day's Range
$1.67 - $2.05
52-Week Range
$0.83 - $2.90
Dividend & Yield
N/A (N/A)

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?